Observational studyCardiovascular and interventional radiology2026
Pharmaceutically Assisted Angioplasty to Relieve Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage-A Retrospective, Single-Center, Observational Comparison of Established and New Treatment Techniques.
Observational study in Cardiovascular and interventional radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo compare differences in efficacy of endovascular vasospasm therapy (EVT) with pharmacological, mechanical or combined treatment.
methodsIn a single-center retrospective analysis, we included 60 patients with EVT after aneurysmal subarachnoid hemorrhage from 2017-2022. EVT treatment groups were: 1. Single or 2. dual vasodilator application, 3. transluminal balloon angioplasty (TBA) alone, with 4. single, or 5. dual vasodilator application, or 6. Stent-Retriever-Angioplasty alone, with 7. single, or 8. dual vasodilator application. Arterial diameters were measured on admission and after treatment. We compared relative increase and significant difference in diameter for each treatment group via multivariable linear regression (SPSS statistics). Age, sex, number of previous treatments and severity of spasm were included as confounding variables.
resultsIn 628 treated vessel segments, dual vasodilator application showed significant difference restoring 4.4% more diameter than single vasodilator application alone (p-.015). TBA alone, with single or dual vasodilator application was most effective, restoring 28.4% more diameter than single vasodilator application alone (p < .001). Stent-Retriever-Angioplasty was more effective with combined dual vasodilator application (p < .001), not with single or no vasodilator combination. Adverse outcomes were recorded in 2.4% of interventions.
conclusionEVT effectiveness remains a key target in vasospasm rescue treatment but relies on the right treatment modality. TBA remains most effective in vessel dilation. Stent-Retriever-Angioplasty may present an alternative to just pharmacological treatment balancing accessibility and risk profile. Using a combination of vasodilators may enhance treatment efficacy but the combination of nimodipine and papaverine shows little effect in our study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.